.svg){kind=small}
Jan-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
MediPharm Labs has shown a consistent performance in the Oil category across several Canadian provinces. In Alberta, the brand has maintained a stronghold at the top position from October 2024 through January 2025, indicating a stable demand and customer loyalty in this region. Similarly, in Ontario, it has consistently held the second position, showcasing its significant presence and competitiveness in the market. Notably, in Saskatchewan, MediPharm Labs climbed to the top position by November 2024 and sustained this rank through January 2025, suggesting a successful strategy or increased consumer preference in this province. In British Columbia, the brand improved its ranking from fifth to third, highlighting a positive trend and potential growth in market share in the Oil category.
In contrast, the Vapor Pens category presents a different scenario for MediPharm Labs. In Alberta, the brand re-entered the rankings in December 2024, securing the 56th position, and improved slightly to the 51st position by January 2025. This suggests a gradual increase in market penetration, although it remains outside the top 30 brands. In Ontario, MediPharm Labs was not ranked in the top 30 until January 2025, when it appeared at the 97th position, indicating a challenging market environment or the need for strategic adjustments to gain a more competitive edge. These rankings highlight the brand's dominant presence in the Oil category while suggesting potential areas for improvement in Vapor Pens within these regions.
Competitive Landscape
In the competitive landscape of the oil category in Ontario, MediPharm Labs consistently held the second rank from October 2024 to January 2025, indicating a stable position in the market. However, despite maintaining its rank, MediPharm Labs faced challenges in sales performance, with a noticeable decline from November 2024 to January 2025. This contrasts with the leading brand, Redecan, which not only retained the top position but also demonstrated a more robust sales trajectory. Meanwhile, Mod, ranked third, showed a positive sales trend, potentially signaling a growing threat to MediPharm Labs' market share. Additionally, NightNight, although consistently in fourth place, exhibited a steady increase in sales, which could further intensify competition. These dynamics suggest that while MediPharm Labs maintains a strong rank, it may need strategic adjustments to counteract the sales momentum of its competitors.
Notable Products
In January 2025, MediPharm Labs' top-performing product was CBN:THC 1:2 Nighttime Formula Oil (30ml) in the Oil category, maintaining its leading position since October 2024 with sales reaching 7017. THC 30 Regular Formula Oil (30ml) continued to hold the second spot consistently across the months. CBN:CBD 1:2 Relax Formula Oil (30ml) also remained stable at third place, showing a slight increase in sales to 4075 in January. CBD 50 Plus Olive Formula Oil (30ml) ranked fourth, consistent with previous months, despite a drop in sales compared to December. Notably, the High CBD Distillate Disposable (1g) emerged in January as a new entry, securing the fifth rank in the Vapor Pens category.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
